Applying Advances in Synthetic Biology to Drug Discovery

An Alliance Bernstein report cites the potential economic impact of synthetic biology in healthcare totaling over $1 trillion annually.  Emerging biotech companies with growing revenue and increasing market cap have demonstrated the capacity to expand drug development possibilities. Hear from companies and investors on pathways for growth, challenges to consider, and lessons learned.